Clay Ritchey is the Chief Executive Officer of Evariant. Clay brings more than 20 years of experience driving growth and innovation in market leading healthcare technology organizations to Evariant. As CEO, Clay is passionate about working with healthcare providers, technology partners, and our employees to transform the way that consumers, patients, and providers engage across the care continuum to build deeper relationships resulting in sustainable growth for our customers.
Clay brings a deep understanding of how to leverage digital marketing and technology tools to accelerate customer acquisition and growth and is excited to partner with healthcare providers in their digital marketing journey. Prior to joining Evariant, Clay served as GM and Chief Marketing Officer of Imprivata, the Healthcare IT security leader, where he helped build one of the most trusted brands in healthcare technology security.
Prior to Imprivata, Clay was the Chief Executive Officer of Equinox Healthcare, a post-acute healthcare services company. At Equinox Healthcare, Clay created a scalable, high performing care delivery platform while driving growth and improved patient outcomes. Prior to Equinox Healthcare, Clay held senior marketing and strategy executive roles at leading healthcare and technology firms such as Hill-Rom IT Solutions and Kronos Incorporated, where he led the launch of new solutions resulting in more than $300 million of incremental revenue growth.
Clay received his MBA from Harvard Business School and his BSEE, with Highest Distinction, from The Pennsylvania State University.
Bill Moschella is the co-founder of Evariant, Inc., a company that provides a SaaS healthcare CRM and big data analytics platform to healthcare providers. He has used his leadership and entrepreneurial skills to build Evariant into a dominant healthcare market leader by helping these organizations execute successful patient and physician engagement strategies.
Bill is a proven visionary with broad experience in software as a service (SaaS), big data, marketing automation, and CRM. He was responsible for raising capital and establishing the strategic product vision for Evariant, a company he has led since 2008. To bolster the company’s market position, Bill has established strategic partnerships with Accenture, Dell, Cloudera, Informatica, Salesforce, and other leading technology companies.
Bill is a sought-after speaker at national healthcare conferences and has written multiple articles for industry publications. He has spoken on the topics of big data, analytics and technology development at HIMSS, Dreamforce, The Digital Healthcare Innovation Summit, and other leading healthcare conferences.
Bill was recognized by the Hartford Business Journal’s “40 Under 40 Award” which honors young professionals in the Greater Hartford area who are excelling in their industries through their leadership roles.
Bill attended the Berklee College of Music and graduated from the University of Vermont with a Bachelor of Arts in music and a minor in philosophy.
Rob is charged with advancing the company's market strategy, developing new key business relationships and growing the customer base. He is a veteran of the technology industry, with more than 20 years of executive experience in leading innovation, business strategy, new business development, sales, finance and operations. He has led large-scale technology projects for healthcare systems, educational institutions and Fortune-100 companies. A particular emphasis has been in helping corporations and healthcare organizations transform the way they go-to-market through the utilization of new technology.
Over the course of his career, Rob has co-founded or joined five embryonic companies leading each through significant growth. Rob holds a Bachelor of Science in Business Administration with a Major in Marketing from Appalachian State University.
Prior to joining HEP in 2009, Dave was a Vice President of Susquehanna Growth Equity, a private equity group focused on growth capital opportunities in the technology sector. From 2002 to 2007, he was the President and Chief Operating Officer of Onward Healthcare, Inc., a WCAS portfolio company that provides human capital services to health care providers. Prior to Onward, from 1999 to 2002, Dave was an Executive Vice President of Pinnacor, Inc., a provider of information and analytical applications where he managed the company’s worldwide operations.
He is currently on the board of directors of Catapult Health, eVariant, HealthQx, Nordic Consulting, and Shyft Analytics. Dave previously served on the board of directors for MobileMD (acquired by Siemens Healthcare) and Privia Health (merged with Brighton Health). He is on the faculty of Columbia Business School and the School of Professional Studies at Columbia University.
Dave is a distinguished graduate of the United States Military Academy and holds an MBA from Harvard Business School.
Chris Schaepe has over 20 years of venture capital experience and invests in areas including cloud, SaaS, enterprise infrastructure as well as mobile technologies and applications. Chris has been named to the Forbes Midas List of top venture capital investors 11 times since its introduction in 2001. He has also backed over 10 first-time CEOs who have led their startup companies though successful IPOs. Chris has served as a director of a number of public companies including eHealth (EHTH), Fusion-io (FIO) and Riverbed Technology (RVBD) where he currently serves as Chairman of the Compensation Committee.
Prior to Lightspeed, Chris was a General Partner of Weiss, Peck & Greer Venture Partners which he joined in 1991 to focus on seed and early-stage investments in technology companies. Previously, he worked in corporate finance and capital markets roles at Goldman, Sachs & Co. after serving as a software engineer at IBM. Chris holds BS and MS degrees in Computer Science and Electrical Engineering from the Massachusetts Institute of Technology and an MBA from Stanford University Graduate School of Business.
Chris enjoys mentoring student entrepreneurs and is involved in startup-related university programs at Stanford and MIT including MIT's Deshpande Center for Technological Innovation. He also has an interest in children's health and education, currently serving as Vice Chairman of the Lucile Packard Foundation for Children's Health and Trustee of Trinity School in Menlo Park, CA.
Jason Kreuziger is a member of the Growth Equity Investing Group within the Merchant Banking Division (MBD) at Goldman Sachs. He is responsible for leading the private equity investments of high-growth businesses in the Software, Business Services and Healthcare sectors in North America. Jason joined Goldman Sachs first in 2008 as a member of the Technology, Media and Telecommunications Investment Banking Group, and returned to Goldman Sachs in 2014 as a Vice President in the Growth Equity Investment Group.
Prior to re-joining the firm, Jason was a member of the private equity investment team at Summit Partners where he focused on investments in the communications technology and software sectors. Before that, he worked as an investment banker at the Royal Bank of Canada and as a management consultant at ZS Associates. Jason is a CFA charterholder, and holds both Series 7 and Series 79 securities licenses.
Jason earned an MBA from Harvard Business School in 2008, and a BBA with honors degree in (i) Finance, Investment and Banking, and (ii) Information Systems from the University of Wisconsin – Madison in 2002.
Outside of work, Jason is an outdoors enthusiast, enjoying distance running, triathlons, hiking, cycling, snowboarding, skiing, and sailing. He also enjoys international travel and collecting local currency from countries he visits.